Apogee Therapeutics (APGE) Other Non-Current Assets (2023 - 2026)
Apogee Therapeutics (APGE) reported Other Non-Current Assets of $8.5 million for Q1 2026, up 16.04% year-over-year from $7.3 million in Q1 2025, and down 1.79% on a QoQ basis from $8.7 million in Q4 2025.
Apogee Therapeutics (APGE) has 4 years of Other Non-Current Assets data on file, last reported at $8.5 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 16.04% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (up 16.04% YoY) and the FY2025 annual result came in at $8.7 million, up 1641.16% from the prior year.
- Other Non-Current Assets slipped to $8.5 million in Q1 2026 per APGE's latest filing, from $8.7 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $8.9 million in Q2 2025 and bottomed at $401000.0 in Q4 2023.
- The 4-year median for Other Non-Current Assets is $3.9 million (2024), against an average of $4.4 million.
- The widest annual swing landed in 2025, when Other Non-Current Assets jumped 1792.52%; it then rose 16.04% in 2026.
- Tracing APGE's Other Non-Current Assets over 4 years: stood at $401000.0 in 2023, then climbed by 24.19% to $498000.0 in 2024, then jumped by 1641.16% to $8.7 million in 2025, then retreated by 1.79% to $8.5 million in 2026.
- Per Business Quant, the three latest APGE Other Non-Current Assets figures stand at $8.5 million (Q1 2026), $8.7 million (Q4 2025), and $8.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Apogee Therapeutics | 5.53 Bn | 4.47 Bn | - | 8.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.52 Mn |
| Dec 31, 2025 | 8.67 Mn |
| Sep 30, 2025 | 8.74 Mn |
| Jun 30, 2025 | 8.86 Mn |
| Mar 31, 2025 | 7.34 Mn |
| Dec 31, 2024 | 498,000.00 |
| Sep 30, 2024 | 514,000.00 |
| Jun 30, 2024 | 468,000.00 |
| Mar 31, 2024 | 401,000.00 |
| Dec 31, 2023 | 401,000.00 |